Lilly to Integrate Dexcom CGM into Personalized Diabetes Management System
Go back to Lilly to Integrate Dexcom CGM into Personalized Diabetes Management System| DexCom, Inc. (NASDAQ: DXCM) | Delayed: 87.44 +2.69 (3.17%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $84.75 | 52 Week High | $96.38 | |||
| Open | $84.81 | 52 Week Low | $47.92 | |||
| Day High | $88.07 | P/E | N/A | |||
| Day Low | $84.53 | EPS | $-0.42 | |||
| Volume | 1,885,213 | |||||
| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1214.23 +28.52 (2.41%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1185.71 | 52 Week High | $88.16 | |||
| Open | $1185.01 | 52 Week Low | $67.88 | |||
| Day High | $1218.00 | P/E | 281.07 | |||
| Day Low | $1184.41 | EPS | $4.32 | |||
| Volume | 895,957 | |||||
